UPS has concluded the previously announced acquisition of Canada-based supply chain company Andlauer Healthcare Group (AHG) for nearly C$2.2bn ($1.6bn). Under the deal, shareholders of AHG received C$55 per share in cash. In April 2025, UPS signed a definitive agreement for the acquisition of AHG. The acquisition enhances UPS' position in complex healthcare logistics by incorporating AHG's specialised cold chain transportation solutions and third-party logistics expertise. The integration of AHG's cold chain network will allow UPS Healthcare customers to benefit from enhanced quality assurance, shorter transit times, improved end-to-end visibility, and expanded global coverage. UPS EVP and international healthcare and supply chain solutions president Kate Gutmann said: “At UPS Healthcare, we are relentlessly focused on quality, improving patient outcomes and advancing healthcare delivery, and we are thrilled that Andlauer Healthcare Group, and its talented employees, share that focus. “We will provide industry-leading services to our global customers, built on a foundation of quality, precision, and speed all designed to help manage high-value, temperature-sensitive treatments.” The deal closed after receiving approval from AHG shareholders and completing customary regulatory assessments. AHG founder and CEO Michael Andlauer will oversee UPS Canada Healthcare and AHG, aiming to expand specialised services and better serve healthcare clients. UPS reported a revenue of $91.1bn for 2024 and provides integrated logistics services in more than 200 countries and territories, employing approximately 490,000 staff. UPS Healthcare services encompass laboratory and clinical trial logistics, cold chain packaging and shipping, inventory management, as well as the storage and fulfilment of medical devices. "UPS concludes Andlauer Healthcare acquisition " was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. View Comments
UPS concludes Andlauer Healthcare acquisition
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...